The differentiation of melanoma and various stromal cells involved in pro-tumorigenic processes, brought about by the β3-AR blockade at the expense of stemness traits, thus hitting the metastatic potential of melanoma, could represent an efficacious strategy to counteract the progression to advanced stages of this malignancy. Here, ADRB3 is linked to melanoma.